CIP2A correlates positively with p-AKT, CD31, and E-cadherin, and negatively with pAMPK, suggesting its role in tumor proliferation, angiogenesis, epithelial plasticity, and metabolic suppression. The gene discussed is PECAM1; the disease is neoplasm.